LSP closes €280m healthcare fund

The fundraise significantly exceeded its original target of €150m.

The investment strategy follows its predecessor, LSP HEF, investing in projects that improve quality of patient care while keeping healthcare costs under control.

LSP HEF held a final close on €112m in March 2014; the fund made 10 investments in total.

LSP is an independent European investment firm headquartered in Amsterdam, providing financing for private and public life sciences companies. The firm has raised more than €1.3bn in investment capital to date, and has offices in Amsterdam, Munich and Boston.

Investors
The LP base includes the European Investment Fund, health insurance companies, institutional investors, asset managers and family offices.

Investments
The new fund will invest in private companies with innovative healthcare products in medical devices, diagnostics and digital health.

The focus will be on Europe and the US with the view to investing in roughly 15 companies.

People
Life Sciences Partners – Rudy Dekeyser (managing partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Healthcare
• Benelux
• Buyout
• Netherlands
• Life Science Partners